These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Between GERD and NERD: the relevance of weakly acidic reflux. de Bortoli N; Ottonello A; Zerbib F; Sifrim D; Gyawali CP; Savarino E Ann N Y Acad Sci; 2016 Sep; 1380(1):218-229. PubMed ID: 27472432 [TBL] [Abstract][Full Text] [Related]
11. Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives. Frazzoni M; de Bortoli N; Frazzoni L; Tolone S; Savarino V; Savarino E Dig Dis Sci; 2017 Aug; 62(8):1881-1889. PubMed ID: 28550489 [TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of Potassium-Competitive Acid Blocker-Resistant Non-Erosive Reflux Disease. Kawami N; Hoshino S; Hoshikawa Y; Takenouchi N; Umezawa M; Hanada Y; Kaise M; Iwakiri K Digestion; 2018; 98(3):194-200. PubMed ID: 29870976 [TBL] [Abstract][Full Text] [Related]
13. Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn. Frazzoni M; de Bortoli N; Frazzoni L; Furnari M; Martinucci I; Tolone S; Farioli A; Marchi S; Fuccio L; Savarino V; Savarino E J Gastroenterol; 2017 Apr; 52(4):444-451. PubMed ID: 27241210 [TBL] [Abstract][Full Text] [Related]
14. How to differentiate non-erosive reflux disease from functional heartburn. Ke MY J Dig Dis; 2012 Dec; 13(12):605-8. PubMed ID: 23134478 [TBL] [Abstract][Full Text] [Related]
15. Direct Comparison of the Efficacy and Safety of Vonoprazan Versus Proton-Pump Inhibitors for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis. Cheng Y; Liu J; Tan X; Dai Y; Xie C; Li X; Lu Q; Kou F; Jiang H; Li J Dig Dis Sci; 2021 Jan; 66(1):19-28. PubMed ID: 32095968 [TBL] [Abstract][Full Text] [Related]
16. Randomised clinical trial: vonoprazan versus lansoprazole for the initial relief of heartburn in patients with erosive oesophagitis. Oshima T; Arai E; Taki M; Kondo T; Tomita T; Fukui H; Watari J; Miwa H Aliment Pharmacol Ther; 2019 Jan; 49(2):140-146. PubMed ID: 30589965 [TBL] [Abstract][Full Text] [Related]
17. Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole. Ashida K; Iwakiri K; Hiramatsu N; Sakurai Y; Hori T; Kudou K; Nishimura A; Umegaki E World J Gastroenterol; 2018 Apr; 24(14):1550-1561. PubMed ID: 29662293 [TBL] [Abstract][Full Text] [Related]
18. Precise role of acid in non-erosive reflux disease. Wang C; Hunt RH Digestion; 2008; 78 Suppl 1():31-41. PubMed ID: 18832838 [TBL] [Abstract][Full Text] [Related]
19. Refractory GERD: increased body mass index is associated with persisting acid exposure but not hypersensitive esophagus or functional heartburn. Viazis N; Karamanolis GP; Anastasiou J; Keyoglou A; Vlachogiannakos J; Ladas SD; Karamanolis DG Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1450-5. PubMed ID: 24047861 [TBL] [Abstract][Full Text] [Related]